Journal of Drug Abuse Open Access

  • ISSN: 2471-853X
  • Journal h-index: 10
  • Journal CiteScore: 1.81
  • Journal Impact Factor: 1.92
  • Average acceptance to publication time (5-7 days)
  • Average article processing time (30-45 days) Less than 5 volumes 30 days
    8 - 9 volumes 40 days
    10 and more volumes 45 days
Reach us +32 25889658

Research Article - (2016) Volume 2, Issue 2

Cocaine Self-Administration Elevates GluN2B within dmPFC Mediating Heightened Cue-Elicited Operant Responding

Karen K Szumlinskim*,Melissa G Wroten,Bailey W Miller,Arianne D Sacramento,Matan Cohen,Osnat Ben-Shahar and Tod E Kippin

Department of Psychological and Brain Sciences & Neuroscience Research Institute, University of California Santa Barbara, Santa Barbara, CA, USA

*Corresponding Author:
Karen K. Szumlinski Ph.D
Department of Psychological and Brain Sciences
Psychology East Building MC-9660
University of California Santa Barbara, Santa Barbara, CA, USA

Received Date: March 30, 2016; Accepted Date: April 15, 2016; Published Date: April 22, 2016

Citation: Szumlinski KK, Wroten MG,Miller BW. Cocaine Self-Administration Elevates GluN2B within dmPFC Mediating Heightened Cue-Elicited Operant Responding. J Drug Abuse. 2016, 2:2.

Visit for more related articles at Journal of Drug Abuse


Cue-elicited drug-craving correlates with hyperactivity within prefrontal cortex (PFC), which is theorized to result from dysregulated excitatory neurotransmission. The NMDA glutamate receptor is highly implicated in addiction-related neuroplasticity. As NMDA receptor function is regulated critically by its GluN2 subunits, herein, we assayed the relation between incubated cue-elicited cocaineseeking following extended access to intravenous cocaine (6 h/d; 0.25 mg/infusion for 10 d) and the expression of GluN2A/B receptor subunits within PFC sub regions during early versus late withdrawal (respectively, 3 vs. 30 days). Cocaine-seeking rats exhibited elevated GluN2B expression within the dorsomedial aspect of the PFC (dmPFC); this effect was apparent at both 3 and 30 days withdrawal and occurred in cocaine-experienced rats, regardless of experiencing an extinction test or not. Thus, elevated dmPFC GluN2B expression appears to reflect a pharmacodynamic response to excessive cocaine intake that is independent of the duration of drug withdrawal or re-exposure to drug-taking context. The functional relevance of elevated dmPFC GluN2B expression for drug-seeking was assessed by the local infusion of the prototypical GluN2B-selective antagonist ifenprodil (1.0 μg/side). Ifenprodil did not alter cue-elicited responding in animals with a history of saline self-administration. In contrast, ifenprodil lowered cue-elicited cocaineseeking, while potentiating cue-elicited sucrose-seeking. Thus, the effects of an intra-dmPFC ifenprodil infusion upon cue reactivity are reinforcer-specific, arguing in favor of targeting GluN2B-containing NMDA receptors as a pharmacological strategy for reducing behavioral reactivity to drug-associated cues with the potential benefit of heightening the reinforcing properties of cues associated with non-drug primary rewards.


Incubation; Craving; Cocaine; NMDA receptor; Prefrontal cortex


The presentation of cocaine-associated cues to human cocaine addicts induces intense drug-craving, increasing the propensity for relapse to drug taking e.g., [1-6]. In cocaine addicts, selfreports of cocaine- craving upon the presentation of drug-related cues or imagery are associated with heightened activation of mPFC [1-3,6-9]. Thus, it is theorized that a history of excessive cocaine consumption produces neural adaptations within the mPFC that render the addict especially vulnerable to relapse, particularly upon presentation of drug-associated stimuli [10-14]. Indeed, considerable evidence has accrued from studies of animal models of addiction to support the hypothesis that cocaine experience produces enduring anomalies in excitatory signaling within mPFC e.g., [14-20] that may be critical for cue-induced drug-seeking. Studies employing the extinctionreinstatement and the forced abstinence models indicate that cue-elicited cocaine-seeking is paralleled by increased indices of mPFC activation, as indexed by heightened expression of immediate early gene products or by increased phosphorylation of intracellular effectors [21-27]. Direct support for the mPFC in drug-seeking has been derived from neuropharmacological studies demonstrating that transient inactivation of this brain area attenuates cue-induced reinstatement of extinguished behavior [28,29], and both neuropharmacological and optogenetic approaches have implicated mPFC in the incubation of cueelicited cocaine-seeking in drug-abstinent animals [24,30]. In particular, neuronal activity within the more ventral, rather than dorsal, aspects of the mPFC (respectively, vmPFC and dmPFC) appears to be particularly important for the intensification of cue-elicited cocaine-seeking during protracted drug withdrawal [24]. Consistent with this, the vmPFC of cocaine-experienced rats exhibits time-dependent increases in the capacity of drug-paired cues to augment the activational state of several neuroplasticityrelated kinases, including extracellular signal-regulated kinase (ERK) [24,25], and the epsilon PKC isozyme (PKCε) [25], which we hypothesize is driven by an incubation of cue-elicited glutamate release within this region [19].

Relatively recently, a “neural rejuvenation” hypothesis of cocaine addiction was proposed, which states that a history of cocaine exposure induces certain plasticity mechanisms normally associated with brain development within the reward circuitry that mediate the highly efficient and unusually stable memory abnormalities that characterize addiction [31]. N-methyl-Daspartate receptors (NMDARs) receptors play a critical role in the synaptic plasticity underpinning learning and memory processes e.g., [32], including that associated with the acquisition, expression and reconsolidation of cocaine-associated memory e.g., [33,34]. NMDARs are heterotetrameric proteins, consisting of two compulsory GluN1 subunits and two modulatory GluN2 subunits (A-D) [35]. GluN2 subunits contain the glutamate binding site e.g., [36,37] and can be differentially regulated by drug experience within several addiction-relevant brain regions, including PFC e.g., [15,38-40]. Relating back to the “neural rejuvenation” theory, specific GluN2 subunits are developmentally regulated in brain, with GluN2B and GluN2D-containing receptors generally dominating during prenatal and early post-natal development and GluN2A-containing receptors becoming more apparent during entry into adolescent and early adulthood stages [41,42]. This developmental switch in GluN2 composition markedly affects the functional properties of NMDARs as evidenced by an age-related reduction in: (1) the agonist sensitivity of the receptor for both glutamate and glycine, (2) reduced current flow due to enhanced rates of channel decay imparted by the GluN2A subunit, (3) differential sensitivity to cations and polyamines, as well as (4) differential coupling to intracellular effectors e.g., [36,37, 41, 43-50]. Thus, adult NMDA receptors are pharmacologically less sensitive to neurotransmitter activation and inactivate more rapidly than those found in juvenile and adolescent animals. As GluN2 subunits are critical for normal cognition c.f., [51-53], this “tuning-down” of NMDA signaling pathways has been implicated in age-related differences in certain types of learning and cognition [54]. Thus, the possibility exists that incubated cocaineseeking and associated cognitive impairments [18, 25] might reflect a time-dependent “rejuvenation” of NMDA receptors within PFC.

Direct support for this hypothesis is currently lacking in the literature. In fact, only a handful of studies have reported on the effects of repeated cocaine upon the relative expression of GluN2 subunits within the reward memory circuitry [40,54-59] and the results vary considerably across studies owing to the very divergent cocaine treatment regimens and paradigms employed [40]. For instance, in our hands, a history of extended (6h/day), but not short (1h/day), access to IV cocaine produces time-dependent changes in the expression of GluN2A and GluN2B within mPFC, with an increase in GluN2B and GluN2A expression observed, respectively, at 14 and 60 days withdrawal [16]. Moreover, we showed that a repeated non-contingent cocaine treatment (7×30 mg/kg) up-regulates GluN2A protein expression in the mPFC of both rats and mice when assessed at 3 weeks withdrawal, with mice exhibiting also a trend towards increased GluN2B protein expression [55]. However, a recent report by Liddie and Itzak [40] demonstrated an important interaction between the scheduling/ patterning of cocaine exposure and drug context for the detection of a cocaine-induced increase in Grin2b and GluN2B, at least within hippocampus. The results of this latter study, coupled with prior evidence that non-pharmacological factors associated with the opportunity to respond for cocaine-associated cues interact with cocaine-taking history to influence the protein expression of glutamate-associated proteins within vmPFC [18,24,25,60], prompted us to examine the relation between cue-elicited cocaine-seeking during withdrawal and the protein expression of GluN2A and GluN2B subunits within mPFC subregions, as well as to assess the functional relevance of increased GluN2B for cueelicited cocaine-seeking.



Male Sprague-Dawley rats (275-325g at the beginning of each experiment) were obtained from Charles River Laboratories (Hollister, CA, USA) and dual-housed in a colony room controlled for temperature (25°C) and humidity (71%), under a 12-hr day/12- hr night cycle (lights on at 20:00 hrs). Animals were given ad libitum access to food and water, except during operant training for food reinforcement (see Lever Response Training below). The animals were allowed to acclimate to the colony room for at least 4 days following arrival. All experimental protocols were consistent with the guidelines of the NIH Guide for Care and Use of Laboratory Animals (NIH Publication No. 80-23, revised 2011) and were approved by the IACUC if the University of California, Santa Barbara.

Lever-response training

To engender lever-pressing behavior, rats were first trained to lever-press under a FR1 schedule of food reinforcement (45 mg pellets; Noyes, Lancaster, NH, USA) in sound-attenuated operant conditioning chambers (30×20×24 cm high; Med Associates Inc., St. Albans, VT) during either a 16-hr overnight training session or during daily 1-h training sessions (depending upon availability of our chambers) as described previously by our group e.g., [16- 19, 25, 60]. For this, rats were food-deprived for 24 h before the initiation of training and maintained on a restricted diet (5-6 g of food per 100 g body weight per day) for the duration of food training. The operant chambers were equipped with two retractable levers, a stimulus light above each lever, a food pellet dispenser outside the operant box and a food trough between the levers, a house light on the wall opposite to the levers, and a speaker connected to a tone generator (ANL-926, Med Associates). During the session, each lever-press on the active lever resulted in delivery of a food pellet only (i.e., no cues were presented). Lever-presses on the inactive lever had no programmed consequences. Rats that failed to exhibit the criterion of a minimum of 200 responses on the active lever during the overnight session or a minimum of 100 responses on the active lever during 2 consecutive 1-hr sessions received additional lever-response training sessions until criterion was met. Following successful acquisition of lever-pressing behavior (1 or 2 over-night sessions; 5-7 days of 1-h daily sessions), food was available ad libitum for the remainder of the study.


Following initial training, animals underwent surgical procedures to implant chronic intravenous (IV) catheters and bilateral guide cannulae into the PFC as described previously by our group e.g., [16-19,25,60]. Under ketamine/xylazine anesthesia (56.25 and 7.5 mg/kg, respectively; Abbott Laboratories, North Chicago, IL, USA), rats were implanted with a chronic silastic catheter (13 cm long; 0.3 mm inner diameter, 0.64mm outer diameter; Dow Corning Corporation, Midland, MI, USA) into the right jugular vein. Atropine (0.04 mg/kg) was administered intramuscularly to minimize respiratory congestion during anesthesia and banamine (2 mg/kg; a non-opiate analgesic) was injected subcutaneously to treat post-surgical pain. Each catheter ran subcutaneously around the shoulder to back where it was secured to a threaded 22 gauge metal guide cannula (Plastics One, Roanoke, VA, USA), which emerged from the midline of the animal’s back perpendicular to the dorsal surface. An obturator covered the open end of the cannula to protect from contamination and the cannula was held in place via a small swatch of Bard Mesh (C.R. Bard Inc., Cranston, RI, USA) to which it was cemented. The mesh was, in turn, laid flat subcutaneously on the animal’s back.

Immediately following the IV catheterization and while still under anesthesia, cocaine rats in the behavioral studies were transferred to a stereotaxic apparatus and implanted with 30-gauge guide cannulae (Plastics One Inc.) above the dorsomedial PFC (dmPFC; AP+2.5 mm, ML +/- 1.0 mm, DV -1.0 mm from Bregma), according to the atlas of Paxinos and Watson (2008), using procedures identical to those described previously by our group [18,25]. Four small screws and cranioplastic cement secured the guide cannulae to the skull. Stylets (Plastics One) were placed into each cannula to prevent occlusion. Sucrose self-administering rats underwent identical intracranial surgical procedures as described for the cocaine animals, but did not undergo IV catheterization surgery. All animals were allowed a minimum of 5 days for recovery and IV catheter patency was maintained by flushing with 0.1 ml of sterile heparin+timentin/saline (60 IU/ml and 100mg/ml, respectively) solution each day.

Self-administration training

Following surgery, rats (n=10-15 per group at the start of each experiment) were trained to self-administer IV cocaine (0.25 mg/0.1ml/infusion; a generous gift from the National Institute on Drug Abuse, Bethesda, MD, USA) during daily 6-hr sessions on a FR1 schedule of reinforcement. At the start of each session, the rat's catheter was connected to a mortorized pump (located outside of the sound attenuated chamber) via a liquid swivel as previously described e.g., [16-19,25,60]. Active lever-presses resulted in a 5-sec activation of the infusion pump and a 20-sec presentation of a stimulus complex, consisting of activation of the white stimulus light above the active lever and the tone generator (78 dB, 2 kHz), during which responses on the active lever had no consequences. Responses on the inactive lever were recorded, but had no programmed consequences. Rats were trained to selfadminister cocaine for 10 sessions and over-dose was prevented by capping the number of cocaine infusions permitted during the first 2 days of training at 100 (day1) and 120 (day2). Rats failing to meet self-administration criterion (minimum of 50 infusions/6-h session for the last 3 days of training) were excluded from the study.

For the immunoblotting study, additional groups of rats were trained to self-administer IV saline (0.1 ml/infusion) during daily 1-h or 6-h sessions (n=12/control group at the start of the experiment) to provide a baseline for determination of cocaineelicited changes in protein expression [18]. We included both Sal1h and Sal6h animals in our immunoblotting experiments to verify that the duration of the saline self-administration session does not significantly influence NMDA subunit expression of relevance to the design of the neuropharmacological study. As it did not, the neuropharmacological study included Sal1h animals, as well as, an additional group of rats trained to lever-press for 45 mg sucrose pellets (Noyes) during daily 6-h sessions, to examine for the reinforcer-specificity of the effects of intracranial ifenprodil upon cue-elicited behavior. All self-administration training and testing occurred during the dark phase of the circadian cycle. Upon completion of the 10 days of self-administration training, animals remained in their home cages in the colony room until testing for cue-elicited lever-pressing behavior or tissue collection at either 3 or 30 days following the last self-administration session.

Tests for cue-elicited lever-pressing

In all but one experiment, saline and cocaine self-administering rats were subjected to a test for cue-elicited cocaine-seeking under extinction conditions. For the immunoblotting experiments, the cue tests were 2 h in duration in order to capture potentially relevant changes in receptor protein expression [18]. The details of the descriptive and inferential statistics regarding the behavioral component of the cocaine immunoblotting study are provided in Ben-Shahar et al. [18]. In brief, Coc6h rats emitted a greater number of cue-reinforced active lever-presses than either Sal1h or Sal6h rats during the 2-h test for drug-seeking. Moreover, the analysis of the change in active vs. inactive lever-presses from 3 to 30 days withdrawal indicated an incubation of cuereinforced responding only in Coc6h rats, as indicated by a timedependent increase in active lever-pressing without any change in inactive lever-pressing behavior. For the neuropharmacological experiment, the cue tests were 30 min in duration, as conducted previously by our group [18,25] and by others e.g., [24]. Cuetesting involved tethering the animals fitted with IV catheters, or placing sucrose-trained animals, in the operant chambers, in which the animals received lever-press response-contingent presentation of the tone-light cue previously paired with saline/ cocaine infusions or sucrose pellet delivery but no infusion/pellet was delivered.


The tissue employed for the immunoblotting studies was the same tissue as that immunoblotted for the expression of Group1 mGluRs [18], Homer proteins [60] and PKCε activity [25] and was derived from gross dissections of the vmPFC (infralimbic cortex + ventral prelimbic cortex) and dmPFC (dorsal prelimbic cortex + anterior cingulate cortex) from: (1) groups of Sal1h, Sal6h and Coc6h rats that underwent a 2-h test for cue-reinforced leverpressing behavior under extinction conductions, conducted at either 3 or 30 days following the end of self-administration training and (2) groups of Sal6h and Coc6h rats that underwent identical self-administration procedures but were not subjected to the behavioral testing procedures (see [18] for details). Rats were sacrificed and tissue collected immediately upon completion of the test session. Protein levels were then assayed by immunoblotting using conventional immunoblotting procedures akin to those described previously by our group e.g., [15,16,38,39,55,61-63]. The details regarding the preparation of tissue homogenates, electrophoresis and protein transfer are provided in Ben-Shahar et al. [18]. As conducted previously in our laboratory e.g., [38,39,62,63], rabbit polyclonal antibodies were used to detect GluN2A and GluN2B (Calbiochem, San Diego, CA; 1:1000 dilution). A rabbit primary anti-calnexin antibody (Stressgen, Ann Arbor, MI; 1:1000 dilution) was used as a control to ensure even protein loading and transfer. Membranes were washed, incubated with horseradish peroxidase-conjugated goat anti-rabbit secondary antibody (Millipore; 1:5,000-1:10,000 dilution) for 90 min, washed again, and immunoreactive bands were detected by enhanced chemiluminescence using either ECL Plus (Amersham Biosciences) or Pierce SuperSignal West Femto (Thermo Fisher Scientific, Rockford, IL). Primary antibodies were stripped off PVDF membranes with ReBlot Plus Strong Antibody Stripping Solution (Millipore). Image J (NIH, Bethesda, MD) was used to quantify immunoreactivity levels. An analysis of the immunoreactivity for calnexin indicated even protein loading and transfer e.g., (Figure 1). Thus, the density X area measurements for each protein band was averaged over the appropriate control samples within each gel (n=3-4/gel) and all bands on that gel were expressed as percent of these control values. The immunoblotting data were analyzed using either t-tests or an IV (cocaine vs. saline) X Withdrawal (3 vs. 30 days) ANOVA and significant interactions were deconstructed using t-tests (α=0.05 for all analyses). Pearson correlational analyses were also conducted to determine whether or not a predictive relation existed between cue-reinforced responding and indices of kinase activity within vmPFC and dmPFC of Sal1h, Sal6h and Coc6h rats (α=0.05 for all analyses).


Figure 1: Regulation of GluN2 subunits within PFC subregions during protracted withdrawal from cocaine self-administration and lack of effect of the opportunity to engage in cocaine-seeking behavior. Total protein expression GluN2A and GluN2B was determined in the dmPFC of rats with a 10-day history of extended access (6 h/d) to either cocaine (Coc6h) or saline (Sal6h) with or without opportunity to engage in cocaine-seeking behavior under extinction conditions. Relative to Sal6h rats, Coc6h rats exhibited increased levels of GluN2B in the dmPFC regardless of withdrawal extent or opportunity to engage in cocaine-seeking. *p<0.05 vs. Sal6h (LSD post-hoc tests).

Microinfusion of ifenprodil

To determine the potential relevance of GluN2B within the dmPFC for drug-seeking behavior, we examined the influence of locally inhibiting GluN2B-containing NMDA receptors using the prototypical antagonist ifenprodil [α-(4-hydroxyphenyl)-β- methyl-4-benzyl-1-piperidine-ethanol(+)-tartrate salt; 1.0 μg/ side). This dose of ifenprodil has been demonstrated previously to attenuate alcohol reinforcement when infused into the dorsal striatum [64], as well as to impair fear-related learning when infused into amygdalar or PFC subregions e.g., [65-67] and thus, was deemed behaviorally relevant. Ifenprodil was dissolved in 0.1% DMSO and a 0.1% DMSO infusion served as a control. The procedures for infusing ifenprodil/vehicle were similar to those described for mGlu1/5 antagonists [18]. In brief, drugs were infused via a 33-gauge microinjector cannulae (12 mm long; Plastics One) at a rate of 0.50 μl/min (total volume of 0.50 μl/ side) and the injectors remained in place for an additional 60 seconds, at which time, the rats were placed into the operant chambers for a 30-min test for cue-reinforced responding, under extinction conditions. Upon completion of this test, brains were removed and standard histochemical procedures were performed to localize microinjector placements within the dmPFC. The data were analyzed using a Self-administration (saline, sucrose or cocaine) X Treatment (vehicle vs. ifenprodil) ANOVA, followed by post-hoc t-tests when appropriate (α=0.05).



A history of extended-access IV cocaine self-administration failed to alter the expression of GluN2A within either the vmPFC or the dmPFC, irrespective of the duration of cocaine withdrawal (Table 1). There was no relation between dmPFC or vmPFC GluN2A levels and lever-pressing behavior in saline self-administering rats (n=43; Pearson tests: p’s>0.35). However, a trend for a positive relation between dmPFC GluN2A levels and lever-pressing behavior was noted for cocaine self-administering animals (data not shown; r=0.46, p=0.07; n=17), while there was absolutely no indication of any relation between vmPFC GluN2A expression and cocaine-seeking (data not shown; Pearson test: p=0.96; n=17). A comparable analysis of GluN2B expression within the vmPFC of saline and cocaine self-administering animals also failed to indicate any effect of cocaine upon protein expression (Table 1) and there was no relation between vmPFC GluN2B levels and lever-pressing behavior in either saline (n=43; Pearson test: p=0.82) or cocaine self-administering rats (n=17; Pearson test: p=0.55)

Protein Region 3 Days Withdrawal 30 days Withdrawal
Statistical Result Saline
Cocaine (n=11) Statistical Result
GluN2A vmPFC 100 ± 5.38 108.8 ± 3.09 t(26)=0.83, p=0.41 100 ± 3.78 91.60 ± 9.04 t(32)=1.01, p=0.32
  dmPFC 100 ± 3.17 113.38 ± 10.33 t(28)=1.66, p=0.11 100 ± 4.55 113.92 ± 7.50 t(31)=1.67, p=0.11
GluN2B vmPFC 100 ± 6.01 107.67 ± 14.76 t(26)=0.56, p=0.58 100 ± 2.85 91.93 ± 9.24 t(32)=1.07, p=0.29

Table 1: Summary of the effects of a history of extended-access to IV cocaine upon the protein expression of GluN2A within both the vmPFC and dmPFC, as well as GluN2b within the vmPFC. As a priori comparisons of protein expression failed to indicate differences between Sal1h and Sal6h animals (t-tests, p’s>0.05), the data for the two saline self-administering groups were collapsed (Saline) prior to statistical comparison with that from cocaine self-administering animals. The numbers represent the mean optical density ± SEMs of the number of animals indicated in parentheses.

In contrast, dmPFC GluN2B expression was elevated in Coc6h rats at both withdrawal time-points with no evidence for a time-dependent change in protein expression (Figure 1, left) [IV effect: F(1,42)=25.11, p<0.0001; interaction: p=0.85]. Despite the above observations, there were no significant relations observed between dmPFC GluN2B expression and lever-pressing behavior in either saline (data not shown; Pearson test: p=0.45; n=43) or cocaine self-administering animals (data not shown; Pearson test: p=0.76; n=17).

To determine whether or not cocaine self-administration experience alone was sufficient to elevate GluN2B levels within dmPFC, we examined for time-dependent changes in dmPFC GluN2B expression in Coc6h and Sal6h rats that were left undisturbed in the home cage prior to tissue collection. This analysis also revealed a time-independent elevation in dmPFC expression of GluN2b in Coc6h rats (Figure 1, right) [IV effect: F(1,57)=11.82, p=0.001; interaction: p=0.40]. These results indicate that a history of extended access to cocaine is sufficient to elevate dmPFC GluN2B expression and that this effect persists into protracted withdrawal.

dmPFC infusion of ifenprodil

As correlation cannot inform as to cause-effect relations, we determined the effect of inhibiting GluN2B-containing NMDA receptors within the dmPFC upon cue-elicited lever-pressing in a test conducted at 3 days withdrawal. As expected, the average number of reinforcers earned during the last 3 days of selfadministration was greatest in rats trained to lever-press for IV cocaine for 6 h/day or sucrose pellets for 6h/day, relative to IV saline (Table 2) [Reinforcer effect: F(2,43)=13.45, p<0.0001; LSD post-hoc tests: SAL vs. SUC or COC, p<0.0001; SUC vs. COC, p=0.87]. Importantly, there were no group differences with respect to the average number of reinforcers earned between rats slated to receive an intra-dPFC infusion of vehicle vs. ifenprodil for any of the self-administration groups (no main Treatment effect or Treatment X Reinforcer interaction, p’s>0.05) and histochemical evaluation of microinjector placement localized infusion to the intended dorsal aspect of the mPFC (Figure 2B).


Figure 2: Impact of dmPFC Ifenprodil on cue-elicited responding in saline-, sucrose- and cocaine-trained rats.Rats with a 10-day history of extended access (6 h/d) to either saline, sucrose, or cocaine received an intra-dmPFC infusion of the GluN2B antagonist, ifenprodil, or vehicle prior to opportunity to engage in cue-elicited responding at 3 days of withdrawal. (A). Cocaine-trained rats exhibited greater lever pressing than sucrose-trained rats following a vehicle, but an ifenprodil, infusion. Both cocaine- and sucrose-trained rats exhibited greater lever pressing than saline-trained rats under both conditions.*p<0.05 vs. Saline; +p<0.05 vs. Sucrose (LSD post-hoc tests).

  Vehicle Ifenprodil
Saline 11 ± 3.4 (6) 6.9 ± 1.4 (7)
Sucrose 123.1 ± 21.4 (7)+ 146.0 ± 29.0 (5)+
Cocaine 110.3 ± 9.0 (10)+ 161.2 ± 42.5 (10)+

Table 2: Comparison of the average number of reinforcers earned by rats trained to self-administer IV saline over daily 1-h sessions (Saline), cocaine over daily 6-h sessions (Cocaine) or to self-administer sucrose pellets over daily 6-h sessions (Sucrose) that were slated to receive an intra-dmPFC infusion of DMSO vehicle or 1.0 μg/side ifenprodil. The numbers represent the means ± SEMs of the number of animals indicated in parentheses. +p<0.05 vs. Saline (LSD post-hoc tests)

On a test of cue-seeking, conducted 3 days following the last self-administration session, the amount of cue-reinforced leverpressing behavior was found to vary as a function of an interaction between self-administration history and intra-dmPFC treatment [Treatment X Reinforcer : F(2,43)=4.16, p=0.02]. Inspection of Figure 2A suggested an opposite effect of ifenprodil infusion upon cue-elicited responding in cocaine- versus sucrose-trained animals. Thus, follow-up tests for simple main effects confirmed that ifenprodil significantly lowered cue-responsiveness in cocaine-experienced rats (p<0.05); however, the potentiating effect of ifenprodil infusion upon sucrose cue reactivity was not statistically significant (p>0.05). The differential regulation of responding for cocaine vs. sucrose-associated cues, coupled with no apparent effect of ifenprodil infusion upon the behavior of saline-trained animals (p>0.05) argues against the contribution of non-specific motor or cognitive effects to the capacity of intra-dmPFC ifenprodil to reduce cocaine-seeking. Moreover, the results argue a necessary role for GluN2B receptor activity within the dmPFC in regulating behavioral reactivity to cocaine-paired cues.


Using immunoblotting procedures, we show that a history of excessive cocaine intake elevates GluN2B expression within the dmPFC early in drug withdrawal and that this effect persists for at least 30 days following cessation of drug-taking. The cocaineinduced rise in dmPFC GluN2B expression was apparent in cocaine-experienced subjects regardless of whether or not the animals were tested for cue-elicited drug-seeking, indicating that elevated dmPFC GluN2B levels are a pharmacodynamic response to self-administered cocaine and/or cocaine withdrawal. Conversely, no cocaine-induced change in vmPFC GluN2B was observed at either time point and no changes in GluN2A levels were observed within either of the mPFC subregions, arguing against a major role for this subunit within the mPFC in regulating cocaine-seeking or the incubation of cocaine-seeking, at least during the first 30 days of cocaine abstinence.

The functional relevance of elevated dmPFC GluN2B expression for cue-elicited cocaine- as well as sucrose-, seeking during shortterm withdrawal was determined by examining the effects of a local infusion of a behaviorally-relevant dose (1.0 μg/side) of the GluN2B-containing NMDA receptor antagonist, ifenprodil [64,66], and the reinforcer-specificity of ifenprodil’s effect was determined by studying cue-elicited sucrose-seeking, as well as lever-pressing behavior in saline self-administering animals. Consistent with prior studies e.g., [18,19,68-70], cocaine- and sucrose-paired cues elicited high rates of lever-pressing behavior, relative to saline-paired cues and this is interpreted to reflect, respectively, cue-elicited cocaine- and sucrose-seeking/craving. Moreover, the efficacy of the cues to elicit operant-responding was increased by pairing with cocaine relative to sucrose, despite equivalent conditioning histories and this is a result in line with findings from other approaches [21,71]. Thus, the second-order conditioning effects of cocaine are greater than those of natural reinforcers, at least in food/water-sated animals. Although intra-dmPFC ifenprodil did not influence behavior in salinetrained animals, GluN2B blockade attenuated cocaine-seeking and potentiated sucrose-seeking such that cues associated with either reinforcer were equivalent in terms of elicitation of responding (Figure 1A). Despite evidence that GluN2B-containing NMDARs regulate cognitive function e.g., [51-53], the apparent opposing effects of ifenprodil upon cue-elicited cocaine- vs. sucrose-seeking argues against some ubiquitous role for dmPFC GluN2B-containing NMDA receptors in the recall of reinforcercue associations or of prior operant learning. Moreover, these data argue that dmPFC GluN2B-containing NMDARs do not play some general role in learning to suppress cue-elicited behavior in the face of null-reinforcer outcomes (i.e., extinction learning), in the motivational properties of secondary reinforcers or in the physical capacity to respond for secondary reinforcers. Whether or not the differential effects of intra-dmPFC ifenprodil upon cocaine- vs. sucrose-seeking reflects reinforcer-specific changes in the complement of GluN2 subunits constituting NMDA receptors within the dmPFC cannot be discerned from the present results as we did not examine for changes in GluN2 subunits in sucrose-trained animals. However, we do know that our training procedures for sucrose and cocaine self-administration result in distinct effects upon cue-elicited glutamate release within mPFC, with sucrose-trained rats exhibiting a cue-elicited rise in extracellular glutamate at 3 days withdrawal, but no change in glutamate at 30 days withdrawal. Conversely, cocaine-trained rats exhibit no cue-elicited change in glutamate during short-term withdrawal, but exhibit a large rise in glutamate when tested at the 30-day withdrawal time-point [19]. Thus, it is clear from our recent work that histories of cocaine- and sucrose-taking produce unique changes in presynaptic aspects of glutamate transmission within PFC. Thus, it seems logical to speculate that the postsynaptic receptors responding to glutamate stimulation would be differentially affected in sucrose-versus cocainetaking rats. Nevertheless, the present neuropharmacological data support the notion that cocaine-induced increases in GluN2b expression within dmPFC contribute, at least in part, to the manifestation of cue-elicited drug-seeking and do so via mechanism(s) independent of those subserving memory recall, motivation or motor activity.

A direct comparison of subunit expression across the two withdrawal time-points revealed that dmPFC GluN2B expression was elevated in cocaine-taking rats at both 3 and 30 days withdrawal (Figure 1). The present results extend prior work from our group demonstrating an increase in mPFC GluN2B expression in rats withdrawn for 14 days from a history of extended (6h/day) access to IV cocaine [18] and provide greater anatomical insight into the localization of this effect to the more dorsal aspect of the region. GluN2B expression is normally developmentally regulated in brain, with levels lower in adulthood relative to younger individuals [41,42]. Thus, the results of this and our earlier study [16] argue that an extensive history of cocaine-taking induces a switch in the subunit composition of NMDARs to that more typical of earlier development, thereby providing evidence of receptor “rejuvenation” [31] or dematuration. In addition to altering sensitivity to cations and polyamines, the GluN2B subunit confers higher agonist sensitivity and increased channel conductance to NMDARs e.g., [41,43-50]. Thus, cocaine-experienced animals likely exhibit NMDAR hyperactivity/hypersensitivity within dmPFC. As NMDARs are critical for bursting activity in mPFC neurons in response to reinforcing stimuli e.g., [72], the higher complement of GluN2B-containing NMDARs within dmPFC is predicted to increase the excitability of dmPFC projections to the nucleus accumbens, so critically involved in cue reactivity and cocaine-seeking behavior e.g., [28,73-75]. This cocaine-elicited change in NMDAR composition (16; present study), coupled with a time-dependent increase in the capacity of cocaineassociated cues to stimulate glutamate release within mPFC [19], could theoretically underpin both cognitive and motivational anomalies in addiction, including pathological psychoreactivity to drug-paired cues.

mPFC GluNB levels normalize by 60 days withdrawal in highly cocaine-experienced rats [16]. Thus, it is not likely that any NMDAR hyperexcitability within dmPFC conferred by elevated GluN2B expression is permanent following a history of excessive cocaine-taking. If anything, the extant data would argue that the opposite might be true as mPFC GluN2A expression is increased markedly, relative to that expressed by saline-taking animals, at 60 days withdrawal in rats with a history of extended cocaine-access [16]. While the present study did not examine for subregional differences in GluNA/B expression at withdrawal times greater than 30 days, these8 NMDAR hypofunction. Consistent with this possibility are data indicating an absence of membrane bistability within mPFC neurons of cocaine-withdrawn rats [20] that is typically generated by the integration of excitatory inputs [76,77]. While the precise mechanism(s) contributing to the dynamics of GluN2 subunit expression are yet unknown, the recent report by Diddie and Itzak [40] indicated that a history of non-contingent cocaine administration elevates both Grin2B mRNA and GluN2B protein expression, at least within hippocampus. Thus, the elevation in GluN2B expression observed selectively within the dmPFC of cocaine-withdrawn rats may very well reflect an increase in both gene transcription and protein translation. Nevertheless, based on what is known regarding the molecular pharmacology of the GluN2B vs. GluN2A subunits, one can speculate how dynamics in the specific GluN2 subunit composition of NMDARs might relate to withdrawal-dependent changes in the excitability of corticocortical and corticofugal projections governing normal executive and cognitive processing to produce the psychobehavioral anomalies characteristic of addiction.

The fact that GluN2 complementation is dynamic during the first few months of cocaine withdrawal [16,54,56] (present study) may have important implications for the scheduling NMDARtargeted pharmacotherapeutics for the treatment of addictionrelated cognitive and motivational dysfunction, with inhibition of GluN2B-containing NMDARs being a potential strategy for curbing craving and alleviating other cognitive anomalies during early withdrawal and inhibition of GluN2A-containing receptors being a potential strategy for facilitating cognition and promoting abstinence during more protracted withdrawal. Herein, inhibition of GluN2B-containing NMDARs using a 1.0 μl/ side dose of ifenprodil attenuated, albeit modestly, cocaine cueelicited drug-seeking when assessed at 3 days withdrawal (Figure 1A). This dose of ifenprodil was selected for the present study as it was demonstrated previously to be effective at reducing alcohol reinforcement when infused into the dorsal striatum [64] and to inhibit the acquisition of a conditioned fear response when infused into the amygdala [66]. However, based on the present immunoblotting results (Figure 1) and results from other studies [16,40,54], higher levels of GluN2B-containing NMDAR inhibition are likely required to more effectively overcome the cocaine withdrawal-induced increase in GluN2B expression observed within cortical tissue. Unfortunately, solubility issues precluded our ability to assay the effects of infusing higher drug concentrations and determine whether or not ifenprodil’s effects on both cocaine- and sucrose-seeking are dose-dependent. Given the encouraging outcome of the neuropharmacological study, particularly with respect to the divergent effects of GluN2B blockade upon cocaine- vs. sucrose-seeking (Figure 2A), future work should attempt to extend the current results in both cocaine- and sucrose-experienced animals using higher ifenprodil (and higher DMSO) concentrations or testing varying doses of different, more soluble, GluN2B-containing NMDA receptor antagonists (e.g., Traxoprodil) [78]. Alternatively, given the recent identification of a novel, functionally relevant, binding mode within a subcavity at the GluN1/2 interface for GluN2B antagonists with nonphenylethanolamine scaffolds (e.g., EVT- 10) [79], future work could compare and contrast the relative efficacy of GluN2B-directed antagonists with distinct binding modes on GluN2B and/or test whether or not combinations of antagonists with distinct binding modes may be more efficacious at influencing the reinforcing properties of drug and non-drug reinforcers. Finally, based on the fact that systemic treatment with both ifenprodil and Traxoprodil are effective at blocking the acquisition and re-consolidation of cocaine-related memory under place-conditioning procedures [40], the possibility exists that the local blockade of GluN2B-containing NMDARs within the dmPFC alone may be insufficient to completely block the capacity of drug-related cues to elicit craving and drug-seeking behavior and it would be worthwhile in future work to assay the effects of systemic (oral) treatment with GluN2B antagonists, including those with nonphenylethanolamine backbones (e.g., EVT-101) [79], on cue-elicited craving both during early and later withdrawal.

Based on our immunoblotting results, we elected to conduct our neuropharmacological study at an early withdrawal timepoint, rationalizing that it was unlikely that the heightened GluN2B levels would differentially contribute to cocaine-seeking during early versus protracted withdrawal (i.e., underpin the development of incubated cocaine-seeking). However, given that a switch in the GluN2 complement of NMDARs appears to occur sometime between 30 and 60 days withdrawal (16; present study), and incubated cocaine-seeking is apparent for at least 60 days withdrawal e.g., [68], it is possible that GluN2B-containing NMDARs within the dmPFC might play a more major role in cueelicited drug-seeking during protracted versus early withdrawal. Indeed, we have recently reported that an incubation of cueelicited glutamate release accompanies the incubation of cueelicited cocaine-seeking [19], but have ruled out the contribution of mGlu1/5 stimulation to the manifestation of incubated responding [18]. Given the important role for NMDARs in neural and behavioral plasticity, future study should seek to determine the relative contribution of GluN2A- vs. GluN2B-containing NMDARs in the incubation of cue-elicited cocaine-seeking during protracted withdrawal, in an effort to understand the neuropharmacology of this relapse-promoting phenomenon and facilitate the design of therapeutics that selectively interfere with the craving-inducing properties of drug-related cues, while sparing (or promoting) the reinforcing properties of non-drug reinforcers.


Funding provided by NIH/NIDA grants DA024038 to KKS and DA027525 to TEK, as well as UCSB Individual Faculty Research Grants to KKS and OBS. The authors would like to thank NIDA for the generous donation of cocaine.


The authors wish to acknowledge the following individuals for their excellent technical assistance and/or assistance with data organization: Rianne R. Campbell, Amanda L. Caruana, Evan J. Gordon and Kyle L. Ploense.